Charles River Laboratories
CRL
#2080
Rank
A$13.65 B
Marketcap
A$277.48
Share price
0.15%
Change (1 day)
-6.56%
Change (1 year)
Categories

P/E ratio for Charles River Laboratories (CRL)

P/E ratio as of December 2025 (TTM): -119

According to Charles River Laboratories 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -119.423. At the end of 2024 the company had a P/E ratio of > 1000.

P/E ratio history for Charles River Laboratories from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024> 1000
202222.8-53.05%
202148.542.45%
202034.015.21%
201929.522.7%
201824.1-43.02%
201742.383.03%
201623.1-7.81%
201525.06.64%
201423.5-4.37%
201324.633.03%
201218.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Repligen
RGEN
> 1000-4,729.62%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-1.36-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
33.1-127.68%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.